Keyphrases
Differential Effects
100%
Transactivation
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
NF-B
100%
Long Terminal Repeat
100%
Viral
40%
Transcription Factor
40%
Tumor Necrosis Factor-α
20%
Binding Site
20%
RelA
20%
Gene Products
20%
Repressor
20%
T Cells
20%
Initiation Site
20%
Target RNA
20%
Enhancer Element
20%
Inhibitory Activity
20%
Synergize
20%
P100
20%
Genetic Enhancer Elements
20%
P105
20%
TAT Peptide
20%
Biochemistry, Genetics and Molecular Biology
Transactivation
100%
Human Immunodeficiency Virus 1
100%
Long Terminal Repeat
100%
Transcription Factors
40%
Herpes Simplex Virus Protein Vmw65
40%
RNA
20%
Binding Site
20%
Transcription
20%
Repressor
20%
Tumor Necrosis Factor
20%
T Cell
20%
Enhancer Region
20%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Transactivation
100%
Long Terminal Repeat
100%
Transcription Factors
40%
Herpes Simplex Virus Protein Vmw65
40%
Repressor Gene
20%
T Cell
20%
Binding Site
20%
Tumor Necrosis Factor
20%
Enhancer Region
20%
Pharmacology, Toxicology and Pharmaceutical Science
Human Immunodeficiency Virus 1
100%
Transcription Factors
40%
Transactivator Protein
40%
Tumor Necrosis Factor
20%
Binding Site
20%
Carisoprodol
20%